Abstract
Primary aldosteronism is one of the important causes of secondary hypertension. However, pregnancy with primary aldosteronism is rare. Eplerenone is an aldosterone antagonist which is used in the treatment of primary aldosteronism. This is a case of successful pregnancy outcome in a young woman who was known to have primary aldosteronism and was on oral eplerenone from preconception. There are only five case reports on eplerenone use during pregnancy in the literature.
Get full access to this article
View all access options for this article.
References
1.
Byrd
JB
Turcu
AF
Auchus
RJ
. Primary aldosteronism: practical approach to diagnosis and management . Circulation 2018 ; 138 : 823 –835 .
2.
Escher
G
. Hyperaldosteronism in pregnancy . Ther Adv Cardiovasc Dis 2009 ; 3 : 123 –132 .
3.
Sahay
M
Sahay
RK
. Low renin hypertension . Indian J Endocrinol Metab 2012 ; 16 : 728 .
4.
Vidyasagar
S
Kumar
S
Morton
A
. Screening for primary aldosteronism in pregnancy . Pregnancy Hypertens 2021 ; 25 : 171 –174 .
5.
Landau
E
Amar
L
. Primary aldosteronism and pregnancy . Ann Endocrinol 2016 ; 77 : 148 –160 .
6.
Morton
A
. Primary aldosteronism and pregnancy . Pregnancy Hypertens: int J Women's Cardiovasc Health 2015 ; 5 : 259 –262 .
7.
Nursal
TZ
Caliskan
K
Ertorer
E
, et al. Laparoscopic treatment of primary hyperaldosteronism in a pregnant patient . Can J Surg 2009 ; 52 : E188 .
8.
Morton
A
Panitz
B
Bush
A
. Eplerenone for Gitelman syndrome in pregnancy . Nephrology 2011 ; 16 : 349 .
9.
Cabassi
A
Rocco
R
Berretta
R
, et al. Eplerenone use in primary aldosteronism during pregnancy . Hypertension 2012 ; 59 : e18 –e19 .
10.
Gunganah
K
Carpenter
R
Drake
WM
. Eplerenone use in primary aldosteronism during pregnancy . Clin Case Rep 2016 ; 4 : 81 –82 .
11.
Morton
A
Laurie
J
. Eplerenone in the management of resistant hypertension with obstructive sleep apnoea in pregnancy . Pregnancy Hypertens 2017 ; 7 : 54 –55 .
12.
Gehlert
J
Morton
A
. Eplerenone as a treatment for resistant hypertension in pregnancy . Obstet Med 2021 ; 14 : 35 –38 .